| Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B P Marcellin, GKK Lau, F Bonino, P Farci, S Hadziyannis, R Jin, ZM Lu, ... New England Journal of Medicine 351 (12), 1206-1217, 2004 | 1540 | 2004 |
| Three-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B EJ Heathcote, P Marcellin, M Buti, E Gane, A Robert, Z Krastev, ... Gastroenterology 140 (1), 132-143, 2011 | 659 | 2011 |
| Peginterferon plus adefovir versus either drug alone for hepatitis delta H Wedemeyer, C Yurdaydìn, GN Dalekos, A Erhardt, Y Çakaloğlu, ... New England Journal of Medicine 364 (4), 322-331, 2011 | 562 | 2011 |
| Sustained response of hepatitis B e antigen-negative patients 3 years after treatment with peginterferon alfa-2a P Marcellin, F Bonino, GKK Lau, P Farci, C Yurdaydin, T Piratvisuth, R Jin, ... Gastroenterology 136 (7), 2169-2179. e4, 2009 | 419 | 2009 |
| Seven-year efficacy and safety of treatment with tenofovir disoproxil fumarate for chronic hepatitis B virus infection M Buti, N Tsai, J Petersen, R Flisiak, S Gurel, Z Krastev, R Aguilar Schall, ... Digestive diseases and sciences 60, 1457-1464, 2015 | 397 | 2015 |
| Late HDV RNA relapse after peginterferon alpha‐based therapy of chronic hepatitis delta B Heidrich, C Yurdaydın, G Kabacam, BA Ratsch, K Zachou, B Bremer, ... Hepatology 60 (1), 87-97, 2014 | 336 | 2014 |
| Ursodeoxycholic acid and atorvastatin in the treatment of nonalcoholic steatohepatitis M Kiyici, M Gulten, S Gurel, SG Nak, E Dolar, G Savci, SB Adim, O Yerci, ... Canadian Journal of Gastroenterology and Hepatology 17 (12), 713-718, 2003 | 335 | 2003 |
| Predicting response to peginterferon α-2a, lamivudine and the two combined for HBeAg-negative chronic hepatitis B F Bonino, P Marcellin, GKK Lau, S Hadziyannis, R Jin, T Piratvisuth, ... Gut 56 (5), 699-705, 2007 | 325 | 2007 |
| Impact of long‐term tenofovir disoproxil fumarate on incidence of hepatocellular carcinoma in patients with chronic hepatitis B WR Kim, R Loomba, T Berg, RE Aguilar Schall, LJ Yee, PV Dinh, ... Cancer 121 (20), 3631-3638, 2015 | 258 | 2015 |
| Soluble forms of extracellular cytokeratin 18 may differentiate simple steatosis from nonalcoholic steatohepatitis Y Yilmaz, E Dolar, E Ulukaya, S Akgoz, M Keskin, M Kiyici, S Aker, ... World journal of gastroenterology: WJG 13 (6), 837, 2007 | 231 | 2007 |
| Peginterferon alfa-2a plus tenofovir disoproxil fumarate for hepatitis D (HIDIT-II): a randomised, placebo controlled, phase 2 trial H Wedemeyer, C Yurdaydin, S Hardtke, FA Caruntu, MG Curescu, ... The Lancet infectious diseases 19 (3), 275-286, 2019 | 202 | 2019 |
| Randomized comparison of tenofovir disoproxil fumarate vs emtricitabine and tenofovir disoproxil fumarate in patients with lamivudine-resistant chronic hepatitis B S Fung, P Kwan, M Fabri, A Horban, M Pelemis, HW Hann, S Gurel, ... Gastroenterology 146 (4), 980-988. e1, 2014 | 194 | 2014 |
| Peginterferon Alfa-2a HBeAg-Negative Chronic Hepatitis B Study Group. Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative … P Marcellin, GK Lau, F Bonino, P Farci, S Hadziyannis, R Jin, ZM Lu, ... N Engl J Med 351 (12), 1206-17, 2004 | 182 | 2004 |
| Quantitative HBsAg and HDV‐RNA levels in chronic delta hepatitis K Zachou, C Yurdaydin, U Drebber, GN Dalekos, A Erhardt, Y Cakaloglu, ... Liver International 30 (3), 430-437, 2010 | 144 | 2010 |
| Kinetics of hepatitis B surface antigen loss in patients with HBeAg-positive chronic hepatitis B treated with tenofovir disoproxil fumarate P Marcellin, M Buti, Z Krastev, RA de Man, S Zeuzem, L Lou, A Gaggar, ... Journal of hepatology 61 (6), 1228-1237, 2014 | 131 | 2014 |
| Anti-HDV IgM as a marker of disease activity in hepatitis delta A Wranke, B Heidrich, S Ernst, B Calle Serrano, FA Caruntu, MG Curescu, ... PloS one 9 (7), e101002, 2014 | 88 | 2014 |
| Long Term Treatment with Tenofovir Disoproxil Fumarate for Chronic Hepatitis B Infection is Safe and Well Tolerated and Associated with Durable Virologic Response with no … P Marcellin, EJ Gane, R Flisiak, HN Trinh, J Petersen, S Gurel, KD Kaita, ... Hepatology 60, 313A-314A, 2014 | 87 | 2014 |
| Long-term clinical outcomes in cirrhotic chronic hepatitis B patients treated with tenofovir disoproxil fumarate for up to 5 years M Buti, S Fung, E Gane, NH Afdhal, R Flisiak, S Gurel, JF Flaherty, ... Hepatology international 9, 243-250, 2015 | 84 | 2015 |
| Association between level of hepatitis D virus RNA at week 24 of pegylated interferon therapy and outcome O Keskin, H Wedemeyer, A Tüzün, K Zachou, X Deda, GN Dalekos, ... Clinical Gastroenterology and Hepatology 13 (13), 2342-2349. e2, 2015 | 80 | 2015 |
| Effects of potassium and iron on macro element uptake of maize. H Celik, BB Așık, S Guerel, AV Katkat | 76 | 2010 |